Literature DB >> 22195528

Drug-induced hypertension: an unappreciated cause of secondary hypertension.

Ehud Grossman1, Franz H Messerli.   

Abstract

A myriad variety of therapeutic agents or chemical substances can induce either a transient or persistent increase in blood pressure, or interfere with the blood pressure-lowering effects of antihypertensive drugs. Some agents cause either sodium retention or extracellular volume expansion, or activate directly or indirectly the sympathetic nervous system. Other substances act directly on arteriolar smooth muscle or do not have a defined mechanism of action. Some medications that usually lower blood pressure may paradoxically increase blood pressure, or an increase in pressure may be encountered after their discontinuation. In general, drug-induced pressure increases are small and transient: however, severe hypertension involving encephalopathy, stroke, and irreversible renal failure have been reported. The deleterious effect of therapeutic agents is more pronounced in patients with preexisting hypertension, in those with renal failure, and in the elderly. Careful evaluation of a patient's drug regimen may identify chemically induced hypertension and obviate unnecessary evaluation and facilitate antihypertensive therapy. Once chemical-induced hypertension has been identified, discontinuation of the causative agent is recommended, although hypertension can often be managed by specific therapy and dose adjustment if continued use of the offending agent is mandatory. The present review summarizes the therapeutic agents or chemical substances that elevate blood pressure and their mechanisms of action.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22195528     DOI: 10.1016/j.amjmed.2011.05.024

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

1.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

2.  2015 Oman Heart Association guidelines for the management of hypertension : practical recommendations from the Oman Heart Association (OHA).

Authors:  Mohammed H El-Deeb; Kadhim J Sulaiman; Abdullah A Al-Riyami; Nabil Mohsin; Mohamed Al-Mukhaini; Mohamed Al-Lamki; Noor Al-Busaidi; Issa Al-Salmi; Jawad Al-Lawati; Najib Al-Rawahi; Mohamed B Al-Riyami; Said Abdul-Rahman; Said Al-Hinai; Batool Jaffer; Ahmed Al-Wahaebi; Hanan Al-Khalili; Matllooba Al-Zadjali
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-11-18

3.  Drug-induced causes of secondary hypertension.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-09

4.  Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome.

Authors:  Neal S Parikh; Andrew D Schweitzer; Robert J Young; Ashley E Giambrone; John Lyo; Sasan Karimi; Anna Knobel; Ajay Gupta; Babak B Navi
Journal:  J Neurol Sci       Date:  2017-06-29       Impact factor: 3.181

5.  Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertension.

Authors:  Teresa Collins; Kelly Gray; Michal Bista; Matt Skinner; Christopher Hardy; Haiyun Wang; Jerome T Mettetal; Alexander R Harmer
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

Review 6.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

7.  Use of Prescription Medications That Potentially Interfere With Blood Pressure Control in New-Onset Hypertension and Treatment-Resistant Hypertension.

Authors:  Andrew Y Hwang; Chintan V Dave; Steven M Smith
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

Review 8.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

Review 9.  Treatment resistant hypertension--investigation and conservative management.

Authors:  Franz Weber; Manfred Anlauf
Journal:  Dtsch Arztebl Int       Date:  2014-06-20       Impact factor: 5.594

Review 10.  Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects.

Authors:  Martin Wehling
Journal:  Eur J Clin Pharmacol       Date:  2014-08-28       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.